Early research (Phase 1)Study completedNCT04319159
What this trial is testing
Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)
Who this might be right for
Actinic Keratoses
Biofrontera Bioscience GmbH 48